Cargando…

25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis

Detalles Bibliográficos
Autores principales:	Hergenroeder, G., Cogen, J., Genatossio, A., McNamara, S., Pascual, M., Hernandez, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518463/ http://dx.doi.org/10.1016/S1569-1993(21)01450-8

Ejemplares similares

Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study
por: Ruddy, Jennifer, et al.
Publicado: (2015)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population
por: Mahan, K., et al.
Publicado: (2021)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
por: Berardis, S., et al.
Publicado: (2020)

P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis
por: Kremer, T., et al.
Publicado: (2021)

P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

Vasculitis in Cystic Fibrosis
por: Sposito, Francesca, et al.
Publicado: (2020)

385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection
por: Tedbury, P., et al.
Publicado: (2022)

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
por: McClenaghan, E., et al.
Publicado: (2021)

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers
por: Hudock, K., et al.
Publicado: (2022)

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis
por: Bezzerri, V., et al.
Publicado: (2022)

343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center
por: Holzum, H., et al.
Publicado: (2021)

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022)

439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 before/after case zero: Valerio Bordino
por: Bordino, V, et al.
Publicado: (2022)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

433 Differential small ribonucleic acid expression analysis reveals transforming growth factor beta role in SARS-CoV-2 infection of the cystic fibrosis airway
por: Hejenkowska, E., et al.
Publicado: (2022)

P231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England
por: Sanderson-Thomas, A., et al.
Publicado: (2021)

314: The COVID-19 pandemic and trends in anxiety and depressive symptoms in adolescents with cystic fibrosis and their caregivers
por: Szentpetery, S., et al.
Publicado: (2021)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019)

Seroprevalence and SARS-CoV-2 antibodies distribution in Portugal following mass vaccination campaign
por: Kislaya, I, et al.
Publicado: (2022)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

Yoga Therapy in Children with Cystic Fibrosis Decreases Immediate Anxiety and Joint Pain
por: McNamara, Christopher, et al.
Publicado: (2016)

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
por: Bain, Robert, et al.
Publicado: (2021)

Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home
por: Terlizzi, V., et al.
Publicado: (2022)

489. SARS-CoV-2 Seroprevalence and Antibody Response Among Pregnant People in Seattle, WA
por: LaCourse, Sylvia, et al.
Publicado: (2021)

Sustained Reduction in Time to Data Entry in the Cystic Fibrosis Foundation Registry
por: Nay, Laura, et al.
Publicado: (2022)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
por: Fainardi, Valentina, et al.
Publicado: (2020)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team
por: Jones, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3qu74omlheaq016vutjdg5pdv